SPOTLIGHT -
OncView™ Podcast: EGFR Exon 20 Insertion as a Therapeutic Target in NSCLC
In an OncView™ program, Zofia Piotrowska, MD, touched on testing, treatment approaches, and therapeutic options for EGFR exon 20 insertion mutations in non–small cell lung cancer.
Recap: Targeted Therapies for EGFR Exon 20 Insertion-Positive NSCLC
Zofia Piotrowska, MD, discusses potential therapies for patients with EGFR exon 20 insertion-positive non–small cell lung cancer.
